Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Pelavo Med is an over-the-counter (OTC) herbal medicinal product developed and marketed by USP Zdrowie for the symptomatic treatment of the common cold. The active ingredient is a liquid extract from the roots of *Pelargonium sidoides* (African geranium). It exhibits a multi-faceted mechanism of action, including antiviral and antibacterial properties, as well as secretolytic effects that facilitate the clearance of mucus from the respiratory tract. It is also known to modulate the immune response by increasing the activity of macrophages and natural killer cells. Unlike other products in the Pelavo line that are marketed as dietary supplements, Pelavo Med is registered as a medicinal product in Poland.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Pelavo Med.